Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Viale

Showing results (211-220 of 302) with videos related to

Pageof 31
Sort By:
British Journal of Cancer|May 29, 2008
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna, V Bagnardi, N Rotmensz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2016
Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trialO Gentilini, E Botteri, P Dadda, et al.
Lancet (London, England)|June 28, 1997
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesU Veronesi, G Paganelli, V Galimberti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptorsM Colleoni, I Minchella, G Mazzarol, et al.
Breast Cancer Research and Treatment|April 3, 2012
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerElisabetta Munzone, E Botteri, A Sciandivasci, et al.
Pathology and Immunopathology Research|January 1, 1986
Ultrastructural immunolabeling in the diagnosis of light-chain-related renal diseaseG A Herrera, R Paul, E A Turbat-Herrera, et al.
Annals of Surgical Oncology|December 18, 2014
Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of OncologyM Intra, G Viale, J Vila, et al.
British Journal of Cancer|March 22, 2007
Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinomaG Puppa, P Maisonneuve, A Sonzogni, et al.
British Journal of Cancer|February 20, 2003
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancerG Pelosi, U Pastorino, F Pasini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2006
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesU Veronesi, C De Cicco, V E Galimberti, et al.
Pageof 31

Showing results (211-220 of 302) with videos related to

Sort By:
Pageof 31
British Journal of Cancer|May 29, 2008
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna, V Bagnardi, N Rotmensz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2016
Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trialO Gentilini, E Botteri, P Dadda, et al.
Lancet (London, England)|June 28, 1997
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesU Veronesi, G Paganelli, V Galimberti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptorsM Colleoni, I Minchella, G Mazzarol, et al.
Breast Cancer Research and Treatment|April 3, 2012
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerElisabetta Munzone, E Botteri, A Sciandivasci, et al.
Pathology and Immunopathology Research|January 1, 1986
Ultrastructural immunolabeling in the diagnosis of light-chain-related renal diseaseG A Herrera, R Paul, E A Turbat-Herrera, et al.
Annals of Surgical Oncology|December 18, 2014
Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of OncologyM Intra, G Viale, J Vila, et al.
British Journal of Cancer|March 22, 2007
Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinomaG Puppa, P Maisonneuve, A Sonzogni, et al.
British Journal of Cancer|February 20, 2003
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancerG Pelosi, U Pastorino, F Pasini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2006
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesU Veronesi, C De Cicco, V E Galimberti, et al.
Pageof 31